#MonthlyPerformanceUpdate

Consolidated sales for March 2026 increased 16.2% year-over-year to exceed 10 billion yen in a single month. All segments recorded significant sales growth: Laboratory +14.6%, Industry +18.1%, Medical +19.3%.

Operating revenue for February 2026 was 5,593 million yen, a 36.7% increase year-over-year. Securities and FX business generated 4,846 million yen, while the crypto asset business recorded revenue of 510 million yen.

Operating revenue for January 2026 was 5,179 million yen, including 4,511 million yen from the Securities & FX business and 471 million yen from the Cryptocurrency business. Year-over-year comparison is unknown.